Text and Data Mining valid from 2019-11-22
Received: 3 September 2019
Accepted: 23 October 2019
First Online: 22 November 2019
Compliance with ethical standards
: Outside the submitted work, MB has received funding for scientific advisory boards, travel and speaker honoraria from Angelini, Astellas, AstraZeneca, Basilea, Bayer, BioMérieux, Cidara, Correvio, Cubist, Menarini, Molteni, MSD, Nabriva, Paratek, Pfizer, Roche, Shionogi, Tetraphase, Thermo Fisher, and The Medicine Company. DRG reports personal fees from Stepstone Pharma GmbH and an unconditioned grant from MSD Italia. PM has received funding for scientific advisory boards travel and speaker honoraria from Astra Zeneca, Basilea, Bayer, Menarini, MSD, Parexel, The Medicines Company, Pfizer and Tetraphase. CE has received speaker honoraria from Angelini, Astellas, AstraZeneca, Menarini, MSD, Nabriva and Pfizer. MS declares no conflict of interest.